Ovarian cancer harbors a loss of cell cycle checkpoints related to TP53 mutations, premature cell cycle progression due to cyclin E1 (CCNE1) amplification, and deficiencies in DNA repair processes [18]. This evidence concerns the gene TP53 and ovarian carcinoma.